Tumor-secreted PGE2 Inhibits CCL5 Production in Activated Macrophages through cAMP/PKA Signaling Pathway
Open Access
- 1 January 2011
- journal article
- Published by Elsevier BV
- Vol. 286 (3), 2111-2120
- https://doi.org/10.1074/jbc.m110.154971
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Characteristics and outcomes of cancer patients in European ICUsCritical Care, 2009
- Immune manipulation of advanced breast cancer: An interpretative model of the relationship between immune system and tumor cell biologyMedicinal Research Reviews, 2008
- Immunodesign of experimental sepsis by cecal ligation and punctureNature Protocols, 2008
- Tumor-derived CCL5 does not contribute to breast cancer progressionBreast Cancer Research and Treatment, 2007
- Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancerBreast Cancer Research, 2007
- Interferon Regulatory Factor 8 Regulates RANTES Gene Transcription in Cooperation with Interferon Regulatory Factor-1, NF-κB, and PU.1Published by Elsevier BV ,2006
- Interferon Regulatory Factor 1 Is an Essential and Direct Transcriptional Activator for Interferon γ-induced RANTES/CCl5 Expression in MacrophagesJournal of Biological Chemistry, 2005
- Unique gene expression profiles of heart allograft rejection in the interferon regulatory factor-1-deficient mouseTransplant Immunology, 2004
- Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinomaInternational Journal of Cancer, 2004
- Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanismCancer Gene Therapy, 2000